Table 1 Clinic-pathological features of LUAD patients in TCGA.

From: Genetic network and gene set enrichment analyses identify MND1 as potential diagnostic and therapeutic target gene for lung adenocarcinoma

Clinical characteristics

Total (N = 486)

%

Duration (d)

769.6 (0–6812)

 

Age at diagnosis (y)

66 (33–88)

 

Gender

Male

222

45.7

Female

264

 

Stage

I

262

54.8

II

112

23.5

III

79

16.5

IV

25

5.2

T

T1

163

33.8

T2

260

53.8

T3

41

8.5

T4

19

3.9

M

M0

333

93.3

M1

24

6.7

N

N0

312

65.8

N1

90

19.0

N2

70

14.8

N3

2

0.4